The global ASD treatment market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. According to the World Health Organization (WHO), ASDs are a diverse group of conditions. They are characterized by some degree of difficulty with social interaction and communication. Other characteristics are atypical patterns of activities and behaviors, such as difficulty with the transition from one activity to another, a focus on details, and unusual reactions to sensations. In 2023, the Centers for Disease Control and Prevention (CDC) reported that approximately 1 in 36 children in the US is diagnosed with an ASD, according to 2020 data. The growing number of cases diagnosed with autism spectrum disorder along with growing awareness about the disease is the major factor driving the growth of the market across the globe.
Browse the full report description of “Autism Spectrum Disorders (ASD) Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others), by Application (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/autism-spectrum-disorders-asd-treatment-market
Various organizations are working in collaboration with the government and private players to propagate awareness related to the disease which is anticipated to propel the ASD market. For instance, in July 2021, the Government published its autism strategy, which sets out how it plans to support autistic adults and children in England over the next five years. Under the strategy, the government plans to invest $12.4 million into finding new ways to reduce diagnosis waiting times for children and young people. Also, invest $3.0 million to improve the quality of adult diagnostic and post-diagnostic pathways and diagnosis waiting times. Furthermore, the government plans to introduce awareness programs by investing $21.9 million to prevent autistic people from falling into mental health crises and provide $24.8 million to local authorities to help people in mental health hospitals back into the community.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Treatment Type
o By Application
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Johnson & Johnson Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Bristol-Myers Squibb, and others, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Autism Spectrum Disorders (ASD) Treatment Market Report Segment
By Treatment Type
By Application
By Distribution Channel
Global Autism Spectrum Disorders (ASD) Treatment Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/autism-spectrum-disorders-asd-treatment-market